Project Grant R01MH141178
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $781,358 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective April 1, 2026, through December 31, 2030. The award supports research to determine the mechanisms and therapeutic potential of novel cholinergic antipsychotics, specifically investigating how drugs such as xanomeline and VU0467154 function as...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Feinstein Institutes for Medical Research a Project Grant of $519,558 under the Mental Health Research Grants program (CFDA 93.242), effective June 15, 2025 through April 30, 2030. The research project focuses on identifying and validating cerebellar-cortical circuitry biomarkers as predictive indicators of antipsychotic treatment response in first-episode psychosis patients. The primary deliverables...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital a $777,016 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective July 1, 2025, through April 30, 2030. This research project investigates the synaptic mechanisms of continuous theta burst stimulation (cTBS), an FDA-cleared repetitive transcranial magnetic stimulation (rTMS) protocol used to treat treatment-resistant depression. The primary deliverables include...
- Federal Grant Award Summary The Laureate Institute for Brain Research, Inc. received a $514,178 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The award funds a five-year research initiative investigating the mechanistic relationships between brain circuits and negative valence system behaviors in treatment-resistant depression (TRD) using low-intensity...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Washington University a Project Grant totaling $284,333 under the Mental Health Research Grants program (CFDA 93.242) on August 4, 2025, for research on mechanism-based dose titration strategies to modify brain electrophysiology during antidepressant therapy for treatment-resistant depression (TRD). The research will be conducted through June 30, 2029, and focuses on developing personalized medicine approaches...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a $1,066,793 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026, with a completion date of January 31, 2028. This research initiative, titled "Early TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression," develops and validates a personalized intermittent theta-burst...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2025, for a five-year project period extending through July 31, 2030. This Project Grant funds a clinical research study examining the role of the anterior hippocampus in major depressive disorder (MDD) pathogenesis....
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1,004,971 Project Grant to the University of Pittsburgh under the Mental Health Research Grants program (CFDA 93.242) on April 8, 2026, with a completion date of February 28, 2029. The award supports "A Day in the Life of the Human Brain: Investigating the Dynamic Interrelationship Between Brain, Cognition, Behavior, and Physiology," a research initiative designed to address a critical knowledge gap...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1,659,568 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 2, 2025, with completion targeted for May 31, 2030. The award funds the ESPRITO EPINET project, which aims to expand a learning health system (LHS) framework for improving treatment outcomes in early first-episode psychosis (FEP) care. The project will enroll an...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded New York University School of Medicine a Project Grant totaling $1,344,223 under the Mental Health Research Grants program (CFDA 93.242), effective September 19, 2025, with an ultimate completion date of August 31, 2028. The award supports the development of molecularly engineered nanocrystals as a noninvasive neuroengineering platform to advance treatment of neurological disorders. The primary deliverables...
Northwestern University's Sponsored Research Division received a $400,000 project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective May 1, 2026, through January 31, 2031. The award funds research to advance understanding of seizure networks in electroconvulsive therapy (ECT), a highly effective treatment for severe treatment-refractory depression. The project will investigate how therapeutic seizures induced during ECT progress through different brain regions and networks, with particular focus on understudied seizure-network nodes such as the piriform cortex, substantia nigra, and cerebellar nuclei that are not adequately captured by standard neuroimaging techniques. The research aims to develop a comprehensive, precise understanding of seizure-network connectivity in both therapeutic seizures during ECT and pathological seizures in epilepsy. By clarifying the relationship between seizure characteristics, brain network involvement, and antidepressant outcomes, the project will generate neurobiological insights and data products that advance mechanistic understanding of ECT's therapeutic effects. These research outputs will contribute to the NIMH mission of transforming understanding and treatment of mental illnesses through basic and clinical research, potentially informing optimization of ECT protocols and identification of biomarkers for treatment response.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $400.0k | 5/5/26 |